CLINICAL_TRIALS
withdrawal
· 2025-04-09
Clinical Trial Update: A Study to Investigate Leramistat in Patients With IPF [Phase 2]
Summary
A Phase 2 clinical trial evaluating Leramistat for idiopathic pulmonary fibrosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Modern Biosciences Ltd | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: WITHDRAWN